Related Experiment Video

Updated: Aug 16, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

The molecular scaffold kinase suppressor of Ras 1 (KSR1) regulates adipogenesis

Robert L Kortum1, Diane L Costanzo, Jamie Haferbier

  • 1Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, 68198-7696, USA.

Molecular and Cellular Biology
|August 19, 2005
PubMed

Insights

Kinase suppressor of Ras 1 (KSR1) levels dictate fat cell differentiation. Low KSR1 enables adipogenesis by coordinating signaling, while high KSR1 inhibits it by altering key protein activity.

Area of Science:

  • Cell biology
  • Molecular signaling
  • Biochemistry

Background:

  • Mitogen-activated protein kinase (MAPK) pathways regulate cell differentiation, but their exact roles are often unclear.
  • The Raf/MEK/extracellular signal-regulated kinase (ERK) pathway has conflicting roles in adipogenesis, potentially promoting or inhibiting it.

Purpose of the Study:

  • To investigate how the molecular scaffold kinase suppressor of Ras 1 (KSR1) influences adipogenesis by modulating the Raf/MEK/ERK/p90 ribosomal S6 kinase (RSK) pathway.
  • To determine the precise role of KSR1 levels in controlling cell fate decisions during differentiation.

Main Methods:

  • Titration of KSR1 expression in cells to precisely control signaling pathway activity.
  • Analysis of ERK and RSK activation dynamics.
  • Assessment of key adipogenic factors, including C/EBPbeta and peroxisome proliferator-activated receptor gamma (PPARγ).

Main Results:

  • Complete deletion of KSR1 abolished adipogenesis in vitro, but low levels rescued this effect.
  • Optimal KSR1 levels synchronized ERK/RSK activation with C/EBPbeta synthesis and phosphorylation, promoting adipogenesis.
  • Excessive KSR1 led to sustained ERK activation, inhibiting adipogenesis via PPARγ phosphorylation.

Conclusions:

  • KSR1 acts as a critical regulator of adipogenesis by fine-tuning the intensity and duration of MAPK signaling.
  • The concentration of KSR1 determines cell fate by modulating the balance between differentiation and proliferation signals.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...